Research groups
Colleges
Najib M Rahman
BM BCh MA (oxon) MSc (LSHTM) FRCP DPhil
Professor of Respiratory Medicine, Director ORTU
- Director, Oxford Respiratory Trials Unit (ORTU).
- Group Head / PI
- Consultant Physician
- National Speciality Lead, Respiratory Disorders, NIHR CRN
- NIHR Senior Investigator
About me
I am Director of the Oxford Respiratory Trials Unit (ORTU).
My personal research area is pleural disease, for which I received MRC Training Fellowship funding to conduct my DPhil. My group has designed and led multiple multicentre randomised trials in pleural disease which have altered treatment for thousands of patients per year, and appear in national and international guidelines. This includes diagnostics in malignant effusion, treatment of malignant effusion, pleural infection and pneumothorax, and the use of ultrasound and thoracoscopy.
In parallel, I lead the Translational Pleural Laboratory, which utilises clinical samples linked to diagnosis and key clinical outcome data to understand the pathobiology of pleural disease, and identify potential new areas of treatment.
Ongoing Research
Our current programme of research is focussed on
1. Practice changing pragmatic trials in all areas of respiratory medicine through collaborative multicentre phase 3 studies (NIHR and HTA funding).
2. Translational science using pleural fluid and pleural biopsies to delineate underlying pathology, phenotype and treatment targets (funded via the Oxford NIHR BRC).
3. Collaborative work across a number of different academic areas including radiology, oncology, surgery and imaging.
Key publications
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Journal article
Butler CC. et al, (2023), The Lancet, 401, 281 - 293
Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Journal article
Hallifax RJ. et al, (2020), Lancet (London, England), 396, 39 - 49
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion
Journal article
Rahman NM. et al, (2015), JAMA, 314, 2641 - 2641
Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion
Journal article
Davies HE. et al, (2012), JAMA, 307, 2383 - 2383
Intrapleural use of tissue plasminogen activator and DNase in pleural infection
Journal article
Rahman NM. et al, (2011), New England Journal of Medicine, 365, 518 - 526
Recent publications
Pleural Infection in Adults
Journal article
Bhatnagar M. et al, (2026), Thoracic Surgery Clinics, 36, 293 - 304
Pleural Management Pathways and Outcomes in Haematological Malignancy-Associated Malignant Pleural Effusion
Journal article
Walsh O. et al, (2026), Journal of Clinical Medicine, 15, 5201 - 5201
Patient perspectives on ultrasound-guided interventions in respiratory medicine: an international, mixed-methods study
Journal article
Jones E. et al, (2026), ERJ Open Research, 12, 01218 - 2025
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).
Journal article
Neilly MDJ. et al, (2026), BMJ open respiratory research, 13
Training in pleural interventions: not just a matter of ‘rights’?
Journal article
Stanton AE. et al, (2026), BMJ Open Respiratory Research, 13, e004257 - e004257
Outperformed by enzymes: why saline lavage falls short of intrapleural enzyme therapy in pleural infection.
Journal article
Lee YCG. and Rahman NM., (2026), The European respiratory journal, 67
Extracellular stressors change BBSome expression of benign mesothelial and primary pleural mesothelioma cells and affect cell adhesion and migration.
Journal article
Jagirdar RM. et al, (2026), Physiological reports, 14
Advances in Diagnosis-Pulmonology.
Journal article
Stone E. et al, (2026), Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 21
Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)
Journal article
Lowe DM. et al, (2026), The Lancet Microbe, 7, 101360 - 101360
British Thoracic Society Quality Standard for Pleural Disease
Journal article
Roberts ME. et al, (2026), BMJ Open Respiratory Research, 13, e003760 - e003760
Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial.
Journal article
Thiboutot J. et al, (2026), JAMA
Outcomes of radiologically diagnosed solitary fibrous tumours of the pleura.
Journal article
Ellayeh M. et al, (2026), ERJ open research, 12, 1018 - 2025
Pleural fluid neutrophil extracellular traps are associated with disease severity and risk of one-year mortality in pleural infection. An observational, international, multicohort study (TORPIDS-3)
Journal article
Chu JY. et al, (2026), European Respiratory Journal, 2600113 - 2600113
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients
Journal article
Butler CC. et al, (2026), New England Journal of Medicine, 394, 1583 - 1594
Vibrotactile positional therapy for the treatment of positional obstructive sleep apnoea: a multicentre, randomised controlled trial
Journal article
Kelly JL. et al, (2026), Thorax, 81, 370 - 379
Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trial
Journal article
Dipper A. et al, (2026), The Lancet Respiratory Medicine, 14, 341 - 349
Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.
Journal article
Gardiner LE. et al, (2026), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Rethinking pleural tuberculosis through the lens of cell-free DNA
Journal article
Bedawi EO. and Rahman NM., (2026), Thorax
A National Evaluation of Intercostal Chest Drain Removal Strategies
Journal article
Veale N. et al, (2026), CHEST, 169, 849 - 858
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study
Journal article
Symes R. et al, (2026), The Lancet Infectious Diseases, 26, 229 - 238
